Published in J Chem Soc Perkin 1 on January 01, 1976
Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (1975) 10.33
Genetic analysis of histone H4: essential role of lysines subject to reversible acetylation. Science (1990) 4.47
Hox genes and the evolution of vertebrate axial morphology. Development (1995) 3.60
Analysis of Hox gene expression in the chick limb bud. Development (1996) 3.47
Regulation of the fission yeast transcription factor Pap1 by oxidative stress: requirement for the nuclear export factor Crm1 (Exportin) and the stress-activated MAP kinase Sty1/Spc1. Genes Dev (1998) 3.27
The cloned dopa decarboxylase gene is developmentally regulated when reintegrated into the Drosophila genome. Cell (1983) 3.08
Sonic hedgehog and Fgf-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud. Cell (1994) 2.98
Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int (1999) 2.82
Wnt signaling maintains the hair-inducing activity of the dermal papilla. Genes Dev (2000) 2.77
Histone H4 and the maintenance of genome integrity. Genes Dev (1995) 2.40
Sonic hedgehog is an endodermal signal inducing Bmp-4 and Hox genes during induction and regionalization of the chick hindgut. Development (1995) 2.25
Aiolos regulates B cell activation and maturation to effector state. Immunity (1998) 2.24
Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors. Eur J Pharmacol (1981) 2.14
The forkhead protein Fkh2 is a component of the yeast cell cycle transcription factor SFF. EMBO J (2000) 1.95
The Mcs4 response regulator coordinately controls the stress-activated Wak1-Wis1-Sty1 MAP kinase pathway and fission yeast cell cycle. Genes Dev (1997) 1.93
Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol (1998) 1.92
Peroxide sensors for the fission yeast stress-activated mitogen-activated protein kinase pathway. Mol Biol Cell (2001) 1.80
Tobramycin and gentamicin concentrations in the serum of normal and anephric patients. Antimicrob Agents Chemother (1973) 1.74
beta-catenin signaling can initiate feather bud development. Development (1999) 1.73
Redox control of AP-1-like factors in yeast and beyond. Oncogene (2001) 1.72
BMPs mediate lateral inhibition at successive stages in feather tract development. Development (1998) 1.56
Association of the cell cycle transcription factor Mbp1 with the Skn7 response regulator in budding yeast. Mol Biol Cell (1999) 1.53
Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature (1976) 1.52
Regulated splicing produces different forms of dopa decarboxylase in the central nervous system and hypoderm of Drosophila melanogaster. EMBO J (1986) 1.50
Letter: Ascorbic acid-induced hemolysis in G-6-PD deficiency. Ann Intern Med (1975) 1.38
CNS and hypoderm regulatory elements of the Drosophila melanogaster dopa decarboxylase gene. Science (1986) 1.23
Getting started: regulating the initiation of DNA replication in yeast. Annu Rev Microbiol (1997) 1.20
Structural and functional architecture of the yeast cell-cycle transcription factor swi6. J Mol Biol (1998) 1.14
Thioredoxin peroxidase is required for the transcriptional response to oxidative stress in budding yeast. Mol Biol Cell (2000) 1.13
DNA synthesis control in yeast: an evolutionarily conserved mechanism for regulating DNA synthesis genes? Bioessays (1992) 1.10
Functionally distinct isoforms of the CRE-BP DNA-binding protein mediate activity of a T-cell-specific enhancer. Mol Cell Biol (1992) 1.08
Delimiting regulatory sequences of the Drosophila melanogaster Ddc gene. Mol Cell Biol (1986) 1.06
Risk factor paradox in hemodialysis: better nutrition as a partial explanation. ASAIO J (2001) 1.05
Impact of lower delivered Kt/V on the survival of overweight patients on hemodialysis. Kidney Int (1999) 1.02
Structure-activity relationships of methionine-enkephalin. J Pharm Pharmacol (1976) 1.01
Differential expression of myogenic regulatory genes and Msx-1 during dedifferentiation and redifferentiation of regenerating amphibian limbs. Dev Dyn (1995) 1.00
Thioredoxin reductase-dependent inhibition of MCB cell cycle box activity in Saccharomyces cerevisiae. J Biol Chem (1997) 0.99
Peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis (1983) 0.99
Abdominal hernia in patients undergoing continuous ambulatory peritoneal dialysis. Arch Intern Med (1982) 0.98
The pathogenesis of acute renal failure in heat stroke. South Med J (1973) 0.93
Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis. Kidney Int (2001) 0.92
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison. Am J Kidney Dis (2001) 0.91
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism. Am J Kidney Dis (2000) 0.90
Vibrometry and uremic peripheral neuropathy. South Med J (1977) 0.90
The Tenckhoff catheter for peritoneal dialysis--an appraisal. Nephron (1982) 0.89
Demographic factors associated with dialysis technique failures among patients undergoing continuous ambulatory peritoneal dialysis. Arch Intern Med (1985) 0.88
Regulation of arterial pressure in the anephric state. Circulation (1970) 0.88
Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients? Clin Nephrol (2001) 0.87
Attenuation of ischemic renal injury with fructose 1,6-diphosphate. J Surg Res (1989) 0.86
Rhabdomyolysis: a complication of parathyroidectomy and calcium supplementation. JAMA (1978) 0.85
Increased plasma aldosterone concentration in response to hemodialysis in nephrectomized man. Circ Res (1972) 0.85
Chemical synthesis and receptor binding of catfish somatostatin: a disulfide-bridged beta-D-Galp-(1-->3)-alpha-D-GalpNAc O-glycopeptide. J Pept Res (2000) 0.84
Myocardial depressant effects of sodium acetate. Cardiovasc Res (1978) 0.84
Coronary revascularization in patients maintained on chronic hemodialysis. Circulation (1977) 0.84
Crystal structure of [Leu5]enkephalin. Science (1979) 0.83
The activation of DNA replication in yeast. Trends Biochem Sci (1995) 0.83
Peritoneal dialysis during peritonitis. Kidney Int (1981) 0.82
Mechanism of attenuated hydrochlorothiazide response during indomethacin administration. Kidney Int (1987) 0.82
A comparison of the cardiovascular effects of sodium acetate, sodium bicarbonate and other potential sources of fixed base in hemodialysate solutions. Trans Am Soc Artif Intern Organs (1977) 0.81
Serial monitoring of T-cell subset ratios with monoclonal antibodies in steroid- and antithymocyte globulin-treated patients with renal allotransplants. Clin Immunol Immunopathol (1984) 0.80
Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease. Kidney Int (1999) 0.80
Effect of hemodialysis on the metabolic clearance rate, plasma concentration and blood production rate of aldosterone in anephric man. J Clin Endocrinol Metab (1973) 0.80
The wild-type nucleotide sequence of the rpoBC-attenuator region of Escherichia coli DNA and its implications for the nature of the rifd18 mutation. Nucleic Acids Res (1984) 0.80
Novel analgesics and molecular rearrangements in the morphine-thebaine group. XVI. Some derivatives of 6,14-endo-etheno-7, 8-dihydromorphine. J Chem Soc Perkin 1 (1969) 0.79
Brain TRH receptors are the same as pituitary TRH receptors. J Pharm Pharmacol (1983) 0.79
Leuprolide acetate in the management of ureteral obstruction caused by endometriosis. Obstet Gynecol (1990) 0.79
Rehabilitation, aging and chronic renal disease. Am J Phys Med Rehabil (1992) 0.79
Circulatory control in hypertension. Circ Res (1970) 0.78
Race-dependent survival disparity on hemodialysis: higher serum aluminum as an independent risk factor for higher mortality in whites. Am J Kidney Dis (2000) 0.78
Host defense mechanisms in continuous ambulatory peritoneal dialysis. Clin Nephrol (1983) 0.77
The use of the Seattle hemodialysis system in renal homotransplantation. Trans Am Soc Artif Intern Organs (1964) 0.77
Biological evaluation of a TRH analogue with a modified proline residue. Neuropharmacology (1980) 0.77
Prostaglandin E2 but not I2 restores furosemide response in indomethacin-treated rats. Am J Physiol (1986) 0.77
Improved analogs and novel delivery systems for somatostatin octapeptides. Metabolism (1996) 0.77
Protection from ischemic renal injury by fructose-1,6-diphosphate infusion in the rat. Circ Shock (1985) 0.77
LeVeen shunt (LS): long-term therapy for idiopathic ascites of chronic renal failure. Proc Clin Dial Transplant Forum (1977) 0.77
Modification of the proline residue of TRH enhances biological activity and inhibits degradation. Eur J Pharmacol (1980) 0.76
Anemia and iron target realization in 1998: clinical management of anemia in 1,639 patients on hemodialysis. ASAIO J (2001) 0.76
Opiate analgesics: the effect of agonist-antagonist character on prolactin secretion. J Pharm Pharmacol (1978) 0.76
The minimal importance of the hollow viscera to peritoneal transport during peritoneal dialysis in the rat. ASAIO Trans (1989) 0.76
Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues. J Med Chem (1998) 0.75
Vomiting in paracetamol poisoning. Br Med J (1980) 0.75
Bactericidal properties of the concentrated artificial kidney bath solution. Appl Microbiol (1966) 0.75
Varying Photoperiod, Ribulose 1,5-Bisphosphate Carboxylase/Oxygenase and CO(2) Uptake in Thalassiosira fluviatilis (Bacillariophyceae). Plant Physiol (1985) 0.75
Oil dialysis for ethchlorvynol intoxication. Clin Pharmacol Ther (1972) 0.75
The significance of analytical toxicology in the treatment of poisoning. J Miss State Med Assoc (1970) 0.75
Use of artificial kidney in cases of poisoning. J Miss State Med Assoc (1970) 0.75
Novel analgesics and molecular rearrangements in the morphine-thebaine group. 3. 7-aminomethyl-6,14-endo-ethenotetrahydrothebaines. J Chem Soc Perkin 1 (1969) 0.75
Circulatory function during chronic hemodialysis. Trans Am Soc Artif Intern Organs (1969) 0.75
Alterations in plasma aldosterone levels in response to acute stimuli in kidney allograft recipients. Surg Forum (1972) 0.75
Influence of hemodialysis on plasma aldosterone concentration in nephrectomized patients. Trans Am Soc Artif Intern Organs (1972) 0.75
The effect of renal angiography on the normal kidney. Surgery (1966) 0.75
What is adequate dialysis? Proc Clin Dial Transplant Forum (1971) 0.75
Artificial kidneys in acute renal failure. J Miss State Med Assoc (1970) 0.75
Acute renal failure. J Miss State Med Assoc (1967) 0.75
The effect of disodium cromoglycate on plasma 17-hydroxycorticoid concentration during exercise. Am Rev Respir Dis (1972) 0.75
Femorosaphenous arteriovenous shunt for hemodialysis. South Med J (1969) 0.75
Blood pressure control in dialyzed patients. Proc Clin Dial Transplant Forum (1971) 0.75
Introduction to life. AORN J (1969) 0.75
Novel analgesics and molecular rearrangements in the morphine-thebaine group. XIV. Substitution in the aromatic nucleus in derivatives of 6,14-endo-ethenotetrahydrothebaine. J Chem Soc Perkin 1 (1969) 0.75